ArticlePolymers2026
Development of Polylactic Acid-Curcumin Composite Films with Dual-Metal-Doped Copper Oxide Nanoparticles for Sustainable Antioxidant, Biocompatible, Photothermal, and Antibacterial Performance.
Article in Polymers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polylactic acid (PLA)-curcumin (CCM) composites, incorporating various contents of surface-functionalized dual-metal-doped copper oxide (SF-M-CuO), were prepared by the solution casting method. Synthesized composite films were evaluated for their antioxidant, biocompatible, photothermal, and antibacterial properties. The 4% CCM exhibits excellent compatibility based on total color difference, antioxidant activity, and controlled curcumin release behavior. In addition, different contents of SF-M-CuO (1-4%) were added to the PLA-4%-CCM polymer matrix. Synthesized composite films were characterized through functional, structural, and topographical analyses. FTIR and XRD analyses confirmed the successful incorporation of CCM and SF-M-CuO into the PLA matrix, which enhanced interfacial interactions and increased the crystallinity index by acting as effective nucleating agents. ABTS and DPPH radical scavenging assays revealed dose-dependent antioxidant activity due to the synergistic effects of CCM and SF-M-CuO. Biocompatibility evaluation using RAW 264.7 macrophage cells demonstrated non-toxic responses and enhanced cell proliferation in PLA-4%-CCM composite films containing up to 3%-SF-M-CuO. Among the fabricated films, PLA-4%-CCM-3%-SF-M-CuO exhibited superior photothermal performance and excellent antibacterial activity against
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.